Memantine rosuvastatin neuroprotection peripheral nerve disease trial

Clinical trial NCT07504198 is a newly registered Phase 2 interventional study evaluating the neuroprotective effects of memantine and rosuvastatin combination therapy for peripheral nerve disease. The trial is registered on ClinicalTrials.gov as a prospective study.

Principal investigators and trial sponsors should ensure all required ClinicalTrials.gov registration elements are complete and current, including recruitment status updates, results reporting, and adverse event data as mandated by applicable federal regulations.